What are you searching for?

Sign in

QOL Medical Approved for Sacrosidase Manufacture

FDA approved wholly owned manufacturing facility in Clearwater, Florida to manufacture substance used to make Sucraid®

QOL Medical, LLC announced that the U.S. Food and Drug Administration has approved the company’s wholly owned manufacturing facility in Clearwater, Florida to manufacture sacrosidase, the drug substance used to make Sucraid® (sacrosidase) Oral Solution.  

The Sucraid® drug shortage has been resolved, and this FDA approval eliminates the need for informed consents, assents, physician acknowledgments, and patient questionnaires for all Sucraid® prescriptions. Sucraid® is now available as a regular prescription exclusively from US Bioservices. 


The long-term supply of Sucraid® continues to be QOL Medical’s top priority. QOL Medical has developed an improved manufacturing process for sacrosidase production, designed and built a wholly owned cGMP-compliant manufacturing facility, and hired an experienced manufacturing and quality team to assure this goal. 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics